The Insides News- The Insides Neo - fistuloclysis, distal feeding, best, alternative to parenteral nutrition, fistula, ostomy, ileostomy, chyme, enteral, oral nutrition, enteromate, intestinal failure, colon cancer, bowel cancer, gut cancer, ostomy appliance, high output, chyme, dehydration, defunctioned, ileus, lars, microbiome, lower interior resection syndrome, incontinent, incontinence, gut health, reversal surgery
Get the latest news from The Insides Company. Stay informed about our global efforts in providing universal access to chyme reinfusion therapy, as we strive to revolutionize patient care and set a new standard of healthcare excellence.

The Insides Company Named as One of the First Companies in the Sir Paul Callaghan 100 Report

July 17, 2023

Press Release

The Insides Company has been named one of the first 16 companies in the Sir Paul Callaghan Top 100 Report.
Read More

The Insides Company and Paripro Sign Distribution Agreement For Chyme Reinfusion‍

July 3, 2023

Press Release

The Insides are proud to introduce Paripro as the sole distributor of our purpose-built chyme reinfusion in Switzerland.
Read More

The Insides Company and Théradial Sign Distribution Agreement for Chyme Reinfusion

June 20, 2023

News

The Insides Company, a medical technology company focused on the development and commercialisation of novel chyme reinfusion therapy (CRT)
Read More

The Insides Company et Théradial signent un accord de distribution pour la réinstillation du chyme

June 20, 2023

News

The Insides Company, société spécialisée dans le développement et la commercialisation de nouveaux dispositifs médicaux permettant la réinst
Read More

The Insides Company Receives PECT Reimbursement in France for its Chyme Reinfusion System

June 15, 2023

News

The Insides Company, a medical technology company focused on the development and commercialisation of novel chyme reinfusion therapy (CRT)
Read More

The Insides Company a obtenu un remboursement dans le cadre d’une prise en charge transitoire (PECT) en France pour son système de réinstillation du chyme intestinal

June 15, 2023

News

The Insides Company, société spécialisée dans le développement et la commercialisation de nouveaux dispositifs médicaux permettant la réinst
Read More

The Insides Company Announces Launch of The Insides Neo

March 31, 2023

Press Release

The Insides Company is proud to announce the launch of The Insides Neo, a world-first chyme reinfusion solution for pediatric and
Read More

The Insides Company and First Medical Company Sign Distribution Agreement for South Africa

March 24, 2023

Press Release

The Insides Company has signed a Distribution Agreement with First Medical Company as the exclusive distributor for The Insides Company
Read More

The Insides Company and Razan Medical Trading Sign Distribution Agreement for the United Arab Emirates

March 20, 2023

Press Release

The Insides Company has signed a Distribution Agreement with Razan Medical Trading. for distributing The Insides Company's products in
Read More

The Insides Company and Sanyko d.o.o. Sign Distribution Agreement for Croatia

January 24, 2023

Press Release

The Insides Company has signed a Distribution Agreement with Sanyko d.o.o. for distributing The Insides Company's products in Croatia. 
Read More

Chyme Reinfusion Included in NZ NIFRS Clinical Guidelines

January 11, 2023

News

Chyme reinfusion therapy has now been included in the New Zealand National Failure & Rehabilitation Service (NZ NIFRS) clinical guidelines. 
Read More

New innovative procedure avoids lengthy hospital stays

December 14, 2022

News

A Swansea Bay patient has been spared the prospect of a six month hospital stay and being fed intravenously thanks to innovative new device.
Read More

The Insides Company Announces First-Patient-In (FPI) Milestone Completed for the REINFUSE Study

November 1, 2022

Press Release

The Insides Company, a leading provider of automated chyme reinfusion solutions, today announced the first patient has been enrolled in
Read More

The Insides Company Launches The World’s First Chyme Reinfusion Medical Registry

July 7, 2022

News

The Insides Company is proud to announce the launch of a first in world chyme reinfusion medical registry.
Read More

Device enables Crohn's patient able to manage own condition

June 20, 2022

News

A Crohn's patient has been able to come off medication thanks to the Insides System
Read More

The Insides Company Announces The Insides System for Chyme Reinfusion is now available on the NHS Supply Chain

June 1, 2022

News

The Insides Company is pleased to announce that The Insides System and The Insides Refill have been added to the NHS Supply Chain
Read More

The Insides Company CEO, Garth Sutherland, Announced as Top 50 Healthcare Technology CEOs of 2022

May 23, 2022

News

Garth Sutherland, CEO of The Insides Company, was announced as one of the Top 50 Healthcare Technology CEOs of 2022
Read More

The Insides Company and GD Medical Announce Distribution Agreement for The Netherlands and Belgium

April 4, 2022

News

GD Medical Pharma BV has been appointed as the distributor for The Insides Company's chyme reinfusion solutions in the Netherlands & Belgium
Read More

The Insides Company Announces NICE Medtech Innovation Briefing (MIB) for The Insides System for Severe Intestinal Failure

March 21, 2022

News

The Insides Company is pleased to announce that NICE has released Medtech Innovation Briefing 286 (MIB286) on The Insides System
Read More

The Insides Company and MM Surgical Announce Distribution Agreement for Slovenia

March 21, 2022

Press Release

The Insides Company is pleased to announce the appointment of MM Surgical as its exclusive Slovenian distributor
Read More

The Insides Company Appoints UK Non-Executive Director And Advisors

February 14, 2022

Press Release

The Insides Company Appoints UK Non-Executive Director And Advisors
Read More

The Insides Company Partners with GBUK Group to Provide Chyme Reinfusion Devices to the United Kingdom & Ireland

February 10, 2022

News

The Insides Company is proud to announce it has partnered with GBUK Group to provide The Insides range of chyme reinfusion medical devices
Read More

Feasibility Study on Postoperative Outcomes of Ileostomy Patients using The Insides System Published in Diseases of Colon & Rectum

October 10, 2021

Press Release

In October 2021, a feasibility study assessing the postoperative outcomes of ileostomy patients performing automated chyme reinfusion using
Read More

New Zealand's $2.85b Healthtech Sector

July 9, 2021

The Insides Company’s CEO, Garth Sutherland spoke with Kathryn Ryan and Andrew Clews about the key challenges being faced by Kiwi healthtech
Read More

Dr Chen Liu wins Scientific Award at the 17th Congress of Intestinal Rehabilitation and Transplant Association (CIRTA)

July 2, 2021

Press Release

Dr Chen Liu from the University of Auckland’s Faculty of Medical & Health Science was announced as the winner of the Scientific Award
Read More

‍The Insides Company and OptiMed Technologies Announce Australia Distribution Agreement

June 29, 2021

Press Release

OptiMed Technologies Pty has been appointed as the exclusive distributor for The Insides Company’s therapeutic chyme reinfusion solutions fo
Read More

The Insides System, distributed by Obex Medical, Wins the 2021 Medical Technology Association of New Zealand (MTANZ) Innovation Award

June 23, 2021

Press Release

The Insides System, distributed by Obex Medical, Wins the 2021 Medical Technology Association of New Zealand (MTANZ) Innovation Award
Read More

The Insides System Receives Gold at the 2021 International Medical Design Excellence Awards

May 19, 2021

Press Release

The Insides System receives Gold Award for design excellence in the Gastrointestinal and Genitourinary Devices Category at the 2021 MDEA
Read More

The Insides Company’s Chyme Reinfusion System Features in The Latest Colorectal Disease Journal

March 29, 2021

Press Release

In March 2019, the ‘Colorectal Disease’ Journal published a case study from Westmead Hospital in Sydney, Australia, titled ‘Chyme reinfusion
Read More

Honorary Life Membership - Association of Coloproctology of Great Britain and Ireland Council

January 5, 2021

News

The Association of Coloproctology of Great Britain and Ireland Council (ACPGBI) awarded Honorary Life Membership to Professor Bissett
Read More

The Insides Company and Obex Medical Announce NZ Distribution Agreement

October 13, 2020

Press Release

Obex Medical Limited has been appointed the official distributor for The Insides Company’s medical devices for the New Zealand Market.
Read More

The Insides Company Promoted to NZTE Focus 700

August 28, 2020

Press Release

The Insides Company (Insides Co.), a provider of innovative products for patients with intestinal failure, is pleased to be working with...
Read More

University of Auckland Researchers Using The Insides System in Randomised Controlled Trial

August 19, 2020

Press Release

The Insides Company’s premier chyme reinfusion device, The Insides System, has been selected by researchers at the University of Auck...
Read More

Faster Recovery From Cancer Surgery

April 21, 2020

News

A clever device invented at The University of Auckland is reducing the recovery time for people who have had surgery for bowel cancer.
Read More

The Insides Company’s Chyme Reinfusion System Features in Latest British Journal of Surgery Article

April 20, 2020

Press Release

The Insides Company is delighted to announce the recent publication of the article in the British Journal of Surgery....
Read More

The Insides System Cleared for Sale

February 1, 2020

News

The Insides System Now Commercially Available in the UK and EU
Read More

The Remarkable Kiwi Surgeon Who’s Helped Hundreds in Nepal

January 27, 2020

News

New Zealander Ian Bissett has been operating on desperately poor patients in Nepal for more than 20 years. He tells Eloise Gibson....
Read More

Contact The Insides Company today to learn more about our revolutionising treatments for intestinal failure patients

Contact The Insides Company
The Insides System - fistuloclysis, distal feeding, best, alternative to parenteral nutrition, fistula, ostomy, ileostomy, chyme, enteral, oral nutrition, enteromate, intestinal failure, colon cancer, bowel cancer, gut cancer, ostomy appliance, high output, chyme, dehydration, defunctioned, ileus, lars, microbiome, lower interior resection syndrome, incontinent, incontinence, gut health, reversal surgery
HomeProductsResourcesAbout UsSupportContact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Intellectual Property
Terms & Conditions

© 2023 The Insides Company. All copyright, design, patent and intellectual property rights existing in our designs and products and in the images, text and design of our website / marketing material are the property of The Insides Company.

Choose Your Language

Selecting language below will change the language for theinsides.co
EnglishFrançaisDanskEspañolDeutscheItaliano
Nederlands
SvenskaPolskiTürk日本語PortuguêsTe Reo MāoriSlovinčinaعربيHrvatski

Popular Searches

Chyme
Fistula
Ileostomy
Enteral
Ostomy appliance
Parenteral nutrition
Intestinal failure